Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
LSD1-mediated demethylation of the DNA damage response factor ATM promotes senescence and organ aging
Yingying Zhang, Chen Yu, Xiaoqin Zhang, Linda Xiaoyan Li, Alice Shasha Cheng, Xiaogang Li
Yingying Zhang, Chen Yu, Xiaoqin Zhang, Linda Xiaoyan Li, Alice Shasha Cheng, Xiaogang Li
View: Text | PDF
Research Article Aging Cell biology

LSD1-mediated demethylation of the DNA damage response factor ATM promotes senescence and organ aging

  • Text
  • PDF
Abstract

Aging occurs heterogeneously across organs, leading to progressive tissue dysfunction. Cellular senescence is a stress response triggered by age-associated insults, yet the mechanisms regulating senescence and organ aging remain incompletely understood. Here, we defined a role for lysine-specific demethylase 1 (LSD1) in DNA damage–mediated senescence and organ aging. LSD1 was upregulated in aged organs and senescent cells. In response to natural aging or ionizing radiation–induced DNA damage, LSD1 interacted with and demethylated ATM at lysine 3,016, as confirmed using a newly generated ATM-K3016me antibody. This modification sustained ATM phosphorylation, amplified DNA damage signaling, and delayed checkpoint recovery, promoting senescence and organ aging. Inhibition of LSD1 accelerated ATM dephosphorylation via WIP1, enhanced DNA repair, reduced senescence and DNA damage, and prevented irradiation-induced hair graying. Elimination of senescent cells with senolytics reduced LSD1 protein in aged organs, indicating a feedback loop between LSD1 and senescence. Mechanistically, LSD1 underwent autophagosome-lysosome degradation through interaction with LC3 and Beclin1, and autophagy impairment during DNA damage contributed to LSD1 accumulation in senescent cells. This study revealed LSD1 as a key regulator of DNA damage–induced senescence and organ aging and suggested that targeting LSD1 may attenuate senescence, delay organ aging, and prevent hair graying.

Authors

Yingying Zhang, Chen Yu, Xiaoqin Zhang, Linda Xiaoyan Li, Alice Shasha Cheng, Xiaogang Li

×

Figure 7

LSD1 is subjected to autophagosome-lysosome degradation during cellular senescence and organ aging.

Options: View larger image (or click on image) Download as PowerPoint
LSD1 is subjected to autophagosome-lysosome degradation during cellular ...
(A) Western blot analysis of the expression of LSD1 in mouse IMCD cells treated with ETO and MG132 with indicated doses. (B and C) Western blot analysis of the expression of LSD1 in mouse IMCD cells treated with ETO, and cotreated with Lys05 (B) or Rapamycin (C) with indicated doses. (D) qRT-PCR analysis of Lsd1 mRNA in mouse IMCD cells treated with ETO and cotreated with Lys05 or Rapamycin for 48 hours. All experiments were repeated at least 3 times; ns, not significant; 1-way ANOVA. (E) Western blot analysis of the expression of LSD1 in nuclear (N) and cytoplasmic (C) fractions isolated from mouse IMCD cells treated with ETO and then Lys05 (5 μM). All experiments were repeated at least 3 times; *P < 0.05; 1-way ANOVA. (F) Representative image and quantification of the immunofluorescence staining for LSD1 (green) and LAMP1 (red) in mouse ETO-induced IMCD cells treated with lys05 (5 μM) or rapamycin (1.5 μM). Scale bar: 25 μm. (G) Immunoprecipitation assay to detect the interaction between ATM and LSD1 in mouse IMCD cells treated with or without Lys05. (H) Western blot analysis of the levels of LSD1, phospho-ATM (p-ATM) and total ATM, p62, LC3B, H3K4me2, p16, and p21 in IR-induced mouse IMCD cells treated with rapamycin or vehicle at the indicated time points. ns, no significance, *P < 0.05.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts